Abstract
Background Trafficking and exploitation for sex or labor affects millions of persons worldwide. To improve healthcare for these patients, in late 2018 new ICD-10 medical diagnosis codes were implemented in the US.
Methods Here we report on a database search of a large US health insurer that contained approximately 47.1 million patients and 0.9 million provider organizations, not limited to large medical systems. We reported on any diagnosis with the new codes between 2018-09-01 and 2022-09-01.
Results The dataset was found to contain 5,262 instances of the ICD-10 codes. Regression analysis of the codes found a 5.8% increase in the uptake of these codes per year, representing a decline relative to 6.7% annual increase in the data. The codes were used by 1,810 different providers (0.19% of total) for 2,793 patients. Of the patients, 1,248 were recently trafficked, while the remainder had a personal history of exploitation. Of the recent cases, 86% experienced sexual exploitation, 14% labor exploitation and 0.8% both types. These patients were predominantly female (83%) with a median age of 20 (interquartile range: 15-35). The patients were characterized by persistently high prevalence of mental health conditions (including anxiety - 21%, post-traumatic stress disorder - 20%, major depression - 18%), sexually-transmitted infections, and high utilization of the emergency department (ED). The first report of trafficking occurred most often outside of a hospital or emergency setting (55%), primarily during primary care and psychiatric visits.
Conclusions Our study strengthens the case for expanding the use of the new ICD-10 codes and studying the barriers to their implementation.
Competing Interest Statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Funding Statement
AM, AG, GM, and BN are full-time employees of Carelon Inc. (a division of Elevance Health Inc.). JH performed the research while employed by Love Justice International, a charity addressing human trafficking. All investigators received no compensation outside of their regular employment. The funder had no role in study design, data collection and analysis, preparation of the manuscript. Elevance Health Inc. approved the manuscript prior to publication.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Elevance institutional review and ethics board deemed the study a retrospective analysis for healthcare operations in accordance with HIPAA and 45 CFR 46.102(f) and waived the requirement for patient informed consent (RITM13415607). All data utilized were de-identified and aggregated.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
expanded data to 4 years, added analysis, trimmed length
Data Availability
The data are not publicly released due to HIPAA regulations and patient privacy. The corresponding author may be contacted to discuss data access following approved agreements.
